Nutrition21 Gets NDI For Arginine Silicate Ingredient
The US Food and Drug Administration has accepted Nutrition 21’s inositol-stabilized arginine silicate (Nitrosigine) as a New Dietary Ingredient (NDI). Michael Satow, President and CEO of Nutrition 21, said: “Nitrosigine is an exciting addition to our ingredient division and we anticipate it will allow our customers to impact consumers in the sports nutrition, cardiovascular health and men’s health categories. Nitrosigine also validates our ability to develop patent-protected NDIs.”
Nitrosigine®, Velositol®, nooLVL®, Lustriva™, Chromax®, Zinmax®, and their associated logos are registered trademarks of Nutrition21, LLC. All third party trademarks are the property of their respective owners. Nutrition21, LLC's products are protected by a number of patents including, but not limited to: US Patent Nos. 6,809,115; 6,803,456; 7,576,132; 8,062,677; 8,933,022; 9,005,637; 9,028,879; 9,119,835; 9,421,170; 9,597,404; 9,675,702; 10,183,049; 10,245,325; and 10,363,222.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.